Opening the Door to ‘Designer Babies’? South Africa’s Genome Editing Guidelines Spark Global Debate
By Bernice Lottering,
Gene Online
| 11. 08. 2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that could be passed to future generations. This controversial move brings South Africa closer to potentially accepting germline editing, a technique currently prohibited in clinical settings worldwide, though the extent of consultation with the country’s scientific community remains unclear.
South Africa Edges Closer to Approving Controversial Genome Editing, Raising Global Concerns
This recent change in South Africa’s health research ethics guidelines introduces language that could pave the way for heritable genome editing in humans, marking a significant shift in global biomedical policy. Heritable human genome editing, also known as germline editing, involves making genetic modifications to embryos, sperm, or eggs in ways that would be inheritable by future generations. If pursued in clinical settings, this would result in genetically modified children, with potential societal ramifications that have sparked ethical and legal debates worldwide. While many nations have adopted policies against germline...
Related Articles
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Simar Bajaj, The New York Times | 11.27.2025
A common cold was enough to kill Cora Oakley.
Born in Morristown, N.J., with virtually no immune system, Cora was diagnosed with severe combined immunodeficiency, a rare genetic condition that leaves the body without key white blood cells.
It’s better...